Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1891-1900 of 9364

Page
per page
  1. N-Methylquipazine dimaleate
    B6353 N-Methylquipazine dimaleate
    Summary: 5-HT3 agonist
      Soluble to 50 mM in H2O
  2. (±)-Myristoylcarnitine chloride
    B6354 (±)-Myristoylcarnitine chloride
    Summary: cholinergic agonist; important intermediates in lipid metabolism
      <10.2 mg/mL
  3. Methiothepin maleate
    B6362 Methiothepin maleate
    Summary: 5-HT antagonist
      insoluble in H2O; insoluble in EtOH; ≥142.4 mg/mL
  4. 5-Methylfurmethiodide
    B6363 5-Methylfurmethiodide
    Summary: muscarinic agonist
      <28.11 mg/mL
  5. NPPB
    B6367 NPPB
    Target: Calcium-activated chloride channels (CaCC)|GPR35
    Summary: inhibitor of chloride channel
      insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL
  6. (±)-Octanoylcarnitine chloride
    B6371 (±)-Octanoylcarnitine chloride
     5 Citation
    Summary: an intermediate in fatty acid metabolism
      ≥36.9 mg/mL
  7. 17-ODYA
    B6373 17-ODYA
    Summary: LTB4 ω-hydroxylase inhibitor
      ≥89.8 mg/mL
  8. (±)-Propionylcarnitine chloride
    B6375 (±)-Propionylcarnitine chloride
    Summary: homolog of acetylcarnitine chloride
      <25.37 mg/mL
  9. Physostigmine hemisulfate
    B6380 Physostigmine hemisulfate
    Summary: cholinesterase inhibitor
      <32.44 mg/mL
  10. Quipazine dimaleate
    B6383 Quipazine dimaleate
    Summary: 5-HT3 receptor agonist
      <44.54 mg/mL

Items 1891-1900 of 9364

Page
per page